Telik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies – StreetInsider.com
Published February 25, 2012 | 
PALO ALTO, Calif., Feb. 21, 2012 /PRNewswire/ — Telik, Inc. (Nasdaq: TELK) currently voiced that a Phase 2 investigator-led Telcyta hearing in hematologic malignancies has been stretched to an one more investigational site, Memorial Sloan-Kettering Cancer Center (MSKCC). Based upon a formula celebrated in Stage 1 of a trial, that is being conducted during a Robert Wood Johnson University Hospital underneath a citation of Joseph R. Bertino
Posted in Info & Tips | 
Announces, expansion, Hematologic, Malignancies, Phase, StreetInsider.com, Telcyta, Telik, trial | 
Leave a commentTelik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies – Yahoo Finance
Published February 22, 2012 | PALO ALTO, Calif., Feb. 21, 2012 /PRNewswire/ — Telik, Inc. (Nasdaq: TELK – News) currently voiced that a Phase 2 investigator-led Telcyta hearing in hematologic malignancies has been stretched to an one more investigational site, Memorial Sloan-Kettering Cancer Center (MSKCC). Based upon a formula celebrated in Stage 1 of a trial, that is being conducted during a Robert Wood Johnson University Hospital underneath a citation of Joseph R. Bertino, MD of The Cancer Institute of New Jersey,
Posted in Info & Tips | Announces, expansion, Finance, Hematologic, Malignancies, Phase, Telcyta, Telik, trial, YAHOO | Leave a comment
Recent Comments